Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer
- PMID: 26653706
- DOI: 10.2217/fon.15.332
Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer
Abstract
Aim: This meta-analysis was conducted to evaluate the diagnostic and prognostic functions of E-cadherin expression in cervical cancer.
Methods: PubMed and other databases were searched for articles associated with E-cadherin and cervical cancer. These articles were published before June 2015 and written in English or Chinese. Random-effects model was used to pool odds ratios on the heterogeneity test in the meta-analysis.
Results: All of 20 studies were analyzed, in which 522 (42.6%) subjects exhibited reduced E-cadherin expression. Evaluation of clinicopathologic features showed that the downregulation of E-cadherin was related to the overall survival, clinicopathological parameters and age.
Conclusion: Downregulation of E-cadherin in cervical cancer patients showed poor overall survival. Therefore, E-cadherinmay be a metastasis-suppressor gene in cervical cancer.
Keywords: E-cadherin; biomarker; cervical cancer; meta-analysis; prognosis.
Similar articles
-
Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.PLoS One. 2013 Jul 29;8(7):e70858. doi: 10.1371/journal.pone.0070858. Print 2013. PLoS One. 2013. PMID: 23923027 Free PMC article.
-
Meta-analysis of downregulated E-cadherin as a diagnostic biomarker for cervical cancer.Arch Gynecol Obstet. 2023 Feb;307(2):331-341. doi: 10.1007/s00404-022-06475-7. Epub 2022 Mar 13. Arch Gynecol Obstet. 2023. PMID: 35279729 Review.
-
Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.Int J Clin Exp Pathol. 2014 Sep 15;7(10):6776-83. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25400758 Free PMC article.
-
Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.PLoS One. 2014 Jun 30;9(6):e99763. doi: 10.1371/journal.pone.0099763. eCollection 2014. PLoS One. 2014. PMID: 24978478 Free PMC article.
-
Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis.Dis Markers. 2016;2016:6594016. doi: 10.1155/2016/6594016. Epub 2016 Mar 16. Dis Markers. 2016. PMID: 27069297 Free PMC article. Review.
Cited by
-
Differential effects of α-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells.Int J Oncol. 2018 Apr;52(4):1117-1128. doi: 10.3892/ijo.2018.4279. Epub 2018 Feb 21. Int J Oncol. 2018. PMID: 29484367 Free PMC article.
-
Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT.J Exp Clin Cancer Res. 2021 Jul 1;40(1):220. doi: 10.1186/s13046-021-02006-5. J Exp Clin Cancer Res. 2021. PMID: 34210327 Free PMC article.
-
Diagnostic significance of a color Doppler ultrasound combined with serum CXCL16 and E-cad in cervical cancer.Transl Cancer Res. 2021 Mar;10(3):1492-1499. doi: 10.21037/tcr-21-123. Transl Cancer Res. 2021. PMID: 35116474 Free PMC article.
-
Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment.Front Oncol. 2021 Jun 2;11:659313. doi: 10.3389/fonc.2021.659313. eCollection 2021. Front Oncol. 2021. PMID: 34150626 Free PMC article.
-
Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression.Cancer Genomics Proteomics. 2025 Mar-Apr;22(2):271-284. doi: 10.21873/cgp.20501. Cancer Genomics Proteomics. 2025. PMID: 39993806 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical